• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Broadcom Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket

    6/13/24 8:16:57 AM ET
    $AEMD
    $AIU
    $AVGO
    $CARA
    Medical/Dental Instruments
    Health Care
    Other Consumer Services
    Real Estate
    Get the next $AEMD alert in real time by email

    Shares of Broadcom Inc. (NASDAQ:AVGO) rose sharply in today's pre-market trading after the company posted stronger-than-expected results for its second quarter.

    The company declared a quarterly dividend of $5.25 per share and also announced a 10-for-1 forward stock split. Broadcom boosted its fiscal year 2024 revenue guidance to approximately $51 billion, up from approximately $50 billion.

    Broadcom shares surged 13.5% to $1,698.20 in the pre-market trading session.

    Here are some other stocks moving in pre-market trading.

    Gainers

    • Neo-Concept International Group Holdings Limited (NASDAQ:NCI) rose 79.3% to $1.17 in pre-market trading.
    • Fangdd Network Group Ltd. (NASDAQ:DUO) shares rose 36.9% to $0.8350 in pre-market trading after surging 5% on Wednesday.
    • Grupo Supervielle S.A.  (NYSE:SUPV) gained 22.7% to $8.05 in pre-market trading after rising 6% on Wednesday.
    • Molecular Partners AG (NASDAQ:MOLN) gained 22.1% to $7.08 in pre-market trading after gaining 16% on Wednesday. Molecular Partners recently announced the debut of their lead Raido-DARPin therapy candidate MP0712, targeting DLL3.
    • Longeveron Inc.  (NASDAQ:LGVN) shares climbed 16% to $2.10 in pre-market trading. Longeveron shares jumped over 120% on Wednesday following the circulation of a Zacks Small Cap Research note valuing the stock at $15.10 per share.
    • Aethlon Medical, Inc. (NASDAQ:AEMD) shares gained 15.3% to $0.6025 in pre-market trading after falling 5% on Wednesday.
    • CaliberCos Inc (NASDAQ:CWD) rose 11.5% to $1.07 in pre-market trading.
    • TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) shares rose 10% to $1.10 in pre-market trading after falling 7% on Wednesday. TRACON Pharmaceuticals recently announced publication of Phase 2 clinical data for TRC102 in patients with glioblastoma in clinical cancer research.
    • Vista Energy, S.A.B. de C.V. (NYSE:VIST) shares rose 7.1% to $47.18 in pre-market trading.

    Losers

    • Assure Holdings Corp. (NASDAQ:IONM) shares declined 58.2% to $0.2174 in pre-market trading.
    • DDC Enterprise Limited (NYSE:DDC) shares declined 26% to $1.14 in pre-market trading. DayDayCook shares jumped 198% on Wednesday after the company announced it has acquired Omsom.
    • PainReform Ltd. (NASDAQ:PRFX) shares fell 19.2% to $0.6250 in pre-market trading after surging around 19% on Wednesday.
    • Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) shares fell 19% to $0.4358 in pre-market trading after gaining 10% on Wednesday.
    • Meta Data Limited (NYSE:AIU) shares dipped 18.3% to $0.3225 in pre-market trading.
    • J.Jill, Inc. (NYSE:JILL) fell 15.7% to $33.36 in pre-market trading. J.Jill priced its public offering of 2 million common stock at $31 per share.
    • Cara Therapeutics Inc (NASDAQ:CARA) shares fell 11.7% to $0.60 in pre-market trading. Cara Therapeutics discontinued clinical program for oral difelikefalin in notalgia paresthetica after KOURAGE-1 study showed no meaningful clinical benefit at any dose compared to placebo.
    • Dave & Buster’s Entertainment, Inc. (NASDAQ:PLAY) shares fell 10.6% to $45.03 in pre-market trading after the company posted downbeat results for its first quarter on Wednesday.
    • EpicQuest Education Group International Limited (NASDAQ:EEIQ) shares declined 10% to $0.8292 in pre-market trading.
    • Virgin Galactic Holdings, Inc. (NYSE:SPCE) shares fell 8.3% to $0.78 in pre-market trading after the company announced it will effect a reverse stock split.

    Now Read This: S&P 500 Tops 5,400 As Federal Reserve Holds Rates Steady, Inflation Eases

    Get the next $AEMD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AEMD
    $AIU
    $AVGO
    $CARA

    CompanyDatePrice TargetRatingAnalyst
    Broadcom Inc.
    $AVGO
    4/8/2026Buy → Neutral
    Seaport Research Partners
    Broadcom Inc.
    $AVGO
    4/3/2026Buy → Hold
    Erste Group
    Broadcom Inc.
    $AVGO
    4/2/2026Buy → Hold
    Erste Group
    Broadcom Inc.
    $AVGO
    2/13/2026$335.00Neutral
    DA Davidson
    Vista Energy S.A.B. de C.V.
    $VIST
    2/4/2026$88.00Buy
    BofA Securities
    Broadcom Inc.
    $AVGO
    1/30/2026$400.00Peer Perform → Outperform
    Wolfe Research
    Molecular Partners AG
    $MOLN
    1/27/2026$13.00Buy
    H.C. Wainwright
    Dave & Buster's Entertainment Inc.
    $PLAY
    1/16/2026$30.00Hold → Buy
    The Benchmark Company
    More analyst ratings

    $AEMD
    $AIU
    $AVGO
    $CARA
    SEC Filings

    View All

    CaliberCos Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - CaliberCos Inc. (0001627282) (Filer)

    4/22/26 6:21:06 PM ET
    $CWD
    Real Estate
    Finance

    Amendment: SEC Form SCHEDULE 13G/A filed by J. Jill Inc.

    SCHEDULE 13G/A - J.Jill, Inc. (0001687932) (Subject)

    4/22/26 9:31:36 AM ET
    $JILL
    Apparel
    Consumer Discretionary

    SEC Form DEFA14A filed by Virgin Galactic Holdings Inc.

    DEFA14A - Virgin Galactic Holdings, Inc (0001706946) (Filer)

    4/21/26 4:48:43 PM ET
    $SPCE
    Transportation Services
    Consumer Discretionary

    $AEMD
    $AIU
    $AVGO
    $CARA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Sheehan Kevin M

    4 - Dave & Buster's Entertainment, Inc. (0001525769) (Issuer)

    4/23/26 4:30:02 PM ET
    $PLAY
    Restaurants
    Consumer Discretionary

    Director Samueli Henry was granted 864 shares, increasing direct ownership by 25% to 4,356 units (SEC Form 4)

    4 - Broadcom Inc. (0001730168) (Issuer)

    4/23/26 4:30:10 PM ET
    $AVGO
    Semiconductors
    Technology

    SEC Form 4 filed by You Harry L.

    4 - Broadcom Inc. (0001730168) (Issuer)

    4/22/26 4:58:53 PM ET
    $AVGO
    Semiconductors
    Technology

    $AEMD
    $AIU
    $AVGO
    $CARA
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for KORSUVA issued to CARA THERAPEUTICS INC

    Submission status for CARA THERAPEUTICS INC's drug KORSUVA (ORIG-1) with active ingredient DIFELIKEFALIN has changed to 'Approval' on 08/23/2021. Application Category: NDA, Application Number: 214916, Application Classification: Type 1 - New Molecular Entity

    8/24/21 12:36:58 PM ET
    $CARA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEMD
    $AIU
    $AVGO
    $CARA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    $AEMD
    $AIU
    $AVGO
    $CARA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    $AEMD
    $AIU
    $AVGO
    $CARA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    The Longevity Trade Is No Longer a Buzzword — It's a $120 Billion Market, and the FDA Just Cleared the First Cellular Rejuvenation Trial

    Issued on behalf of Avaí Bio, Inc. Companies mentioned in this commentary include: Avaí Bio, Inc. (OTCQB:AVAI), Eli Lilly and Company (NYSE:LLY), Novo Nordisk A/S (NYSE:NVO), Viking Therapeutics, Inc. (NASDAQ:VKTX), Longeveron Inc. (NASDAQ:LGVN). Key Takeaways: The global anti-aging market generated more than $85 billion in 2025 and is projected to approach $120 billion by 2030, with private investment in longevity science more than doubling to $8.49 billion across 325 deals last year.The U.S. FDA approved 50 new drugs in 2024 and 46 in 2025 — including what researchers are calling the first drug class of "longevity therapeutics" — while big pharma spent more than $65 billion acquiring bi

    4/23/26 6:15:00 AM ET
    $LGVN
    $LLY
    $NVO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Broadcom Expands Collaboration with Google Cloud on Cloud Network Insights

    LAS VEGAS, April 22, 2026 (GLOBE NEWSWIRE) -- Broadcom Inc. (NASDAQ:AVGO) today announced an expanded collaboration with Google Cloud on their new Cloud Network Insights service enabled by AppNeta by Broadcom. Cloud Network Insights provides end-to-end network observability to help organizations manage application and network experience, detect issues and diagnose root cause across complex, multi-cloud, hybrid and agentic environments. Building on its existing partnership with Broadcom, Google Cloud developed Cloud Network Insights as a first-party offering exclusively for Google Cloud users. With the deep network insights of Broadcom integrated with the scale of Google Cloud, Cloud Netwo

    4/22/26 9:00:00 AM ET
    $AVGO
    Semiconductors
    Technology

    Caliber Advances Hyatt Studios Development Platform Across Three High-Growth Markets

    SCOTTSDALE, Ariz., April 22, 2026 (GLOBE NEWSWIRE) -- Caliber (NASDAQ:CWD), a diversified real estate and digital asset management platform, today announced that it continues to execute on its multi-market Hyatt Studios development platform, advancing three hospitality projects across high-conviction markets: Steamboat Springs, CO; Riverwalk/Scottsdale, AZ; and Georgetown, TX. The first project in Steamboat Springs closed acquisition and construction financing in April 2026 and is expected to break ground during the second quarter of 2026. The platform represents a focused effort to capitalize on supply-constrained markets and growing demand for extended-stay hospitality. The announcement

    4/22/26 7:15:00 AM ET
    $CWD
    Real Estate
    Finance

    Broadcom downgraded by Seaport Research Partners

    Seaport Research Partners downgraded Broadcom from Buy to Neutral

    4/8/26 8:26:44 AM ET
    $AVGO
    Semiconductors
    Technology

    Broadcom downgraded by Erste Group

    Erste Group downgraded Broadcom from Buy to Hold

    4/3/26 10:44:59 AM ET
    $AVGO
    Semiconductors
    Technology

    Broadcom downgraded by Erste Group

    Erste Group downgraded Broadcom from Buy to Hold

    4/2/26 9:25:55 AM ET
    $AVGO
    Semiconductors
    Technology

    SVP, Chief Legal Officer Rodriguez Rodolfo Jr bought $14,673 worth of shares (730 units at $20.10), increasing direct ownership by 5% to 14,500 units (SEC Form 4)

    4 - Dave & Buster's Entertainment, Inc. (0001525769) (Issuer)

    1/20/26 4:30:17 PM ET
    $PLAY
    Restaurants
    Consumer Discretionary

    Director You Harry L. bought $325,129 worth of shares (1,000 units at $325.13), increasing direct ownership by 3% to 36,602 units (SEC Form 4)

    4 - Broadcom Inc. (0001730168) (Issuer)

    12/22/25 5:34:40 PM ET
    $AVGO
    Semiconductors
    Technology

    Director You Harry L. bought $1,227,870 worth of shares (3,550 units at $345.88), increasing direct ownership by 11% to 35,602 units (SEC Form 4)

    4 - Broadcom Inc. (0001730168) (Issuer)

    9/10/25 9:07:35 PM ET
    $AVGO
    Semiconductors
    Technology

    $AEMD
    $AIU
    $AVGO
    $CARA
    Leadership Updates

    Live Leadership Updates

    View All

    Broadcom Announces Planned Chief Financial Officer Transition

    Amie Thuener, Experienced Technology Executive, to be Appointed as Chief Financial OfficerKirsten M. Spears to Retire as Chief Financial OfficerPALO ALTO, Calif., April 2, 2026 /PRNewswire/ -- Broadcom Inc. (NASDAQ:AVGO), a global technology leader that designs, develops and supplies semiconductor and infrastructure software solutions, today announced the appointment of Amie Thuener as Chief Financial Officer of Broadcom, effective June 12, 2026. This appointment follows the retirement of Kirsten M. Spears as Chief Financial Officer, who will continue in her role until that time and will serve as an advisor for nine months to ensure a smooth transition. Ms. Thuener, an experienced technology

    4/2/26 4:15:00 PM ET
    $AVGO
    Semiconductors
    Technology

    Virgin Galactic Appoints Megan Prichard as Chief Growth Officer

    Veteran technology leader and former Uber executive to drive revenue growth, market expansion and customer acquisition for human spaceflight and research missions Virgin Galactic Holdings, Inc. (NYSE:SPCE) ("Virgin Galactic" or the "Company"), a leader in commercial spaceflight and advanced aerospace technology, today announced the appointment of Megan Prichard as its new Chief Growth Officer (CGO), effective April 6. In this newly established role, Prichard will lead the Company's integrated growth and revenue strategy across all business lines while strengthening Virgin Galactic's position as the premier platform for suborbital spaceflight expeditions and scientific research. Prichard

    3/23/26 4:05:00 PM ET
    $BL
    $SPCE
    Computer Software: Prepackaged Software
    Technology
    Transportation Services
    Consumer Discretionary

    Vertiv Holdings, Lumentum Holdings, Coherent, and EchoStar Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600

    NEW YORK, March 6, 2026 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices: NAPCO Security Technologies Inc. (NASD: NSSC) will replace Alexander & Baldwin Inc. (NYSE:ALEX) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, March 13. An investor group comprised of MW Group and funds affiliated with DivcoWest and Blackstone Real Estate is acquiring Alexander & Baldwin in a deal that is expected to close soon, pending final closing conditions.The following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 will take effect before the market opens on M

    3/6/26 6:39:00 PM ET
    $AGX
    $AHRT
    $AIG
    Engineering & Construction
    Consumer Discretionary
    Real Estate
    Finance

    $AEMD
    $AIU
    $AVGO
    $CARA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Fangdd Network Group Ltd.

    SC 13G - Fangdd Network Group Ltd. (0001750593) (Subject)

    12/16/24 4:26:40 PM ET
    $DUO
    Real Estate
    Finance

    Amendment: SEC Form SC 13G/A filed by Fangdd Network Group Ltd.

    SC 13G/A - Fangdd Network Group Ltd. (0001750593) (Subject)

    12/16/24 4:24:27 PM ET
    $DUO
    Real Estate
    Finance

    Amendment: SEC Form SC 13G/A filed by TRACON Pharmaceuticals Inc.

    SC 13G/A - Tracon Pharmaceuticals, Inc. (0001394319) (Subject)

    11/14/24 8:51:58 PM ET
    $TCON
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AEMD
    $AIU
    $AVGO
    $CARA
    Financials

    Live finance-specific insights

    View All

    The Longevity Trade Is No Longer a Buzzword — It's a $120 Billion Market, and the FDA Just Cleared the First Cellular Rejuvenation Trial

    Issued on behalf of Avaí Bio, Inc. Companies mentioned in this commentary include: Avaí Bio, Inc. (OTCQB:AVAI), Eli Lilly and Company (NYSE:LLY), Novo Nordisk A/S (NYSE:NVO), Viking Therapeutics, Inc. (NASDAQ:VKTX), Longeveron Inc. (NASDAQ:LGVN). Key Takeaways: The global anti-aging market generated more than $85 billion in 2025 and is projected to approach $120 billion by 2030, with private investment in longevity science more than doubling to $8.49 billion across 325 deals last year.The U.S. FDA approved 50 new drugs in 2024 and 46 in 2025 — including what researchers are calling the first drug class of "longevity therapeutics" — while big pharma spent more than $65 billion acquiring bi

    4/23/26 6:15:00 AM ET
    $LGVN
    $LLY
    $NVO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    DDC Enterprise Reports Record Revenue and Positive Adjusted EBITDA for Fiscal Year 2025

    - Core consumer food business demonstrated continued operating improvement and margin expansion - Launched Bitcoin treasury strategy and reached 2,383 BTC as of April 21, 2026 DDC Enterprise Limited (NYSEAMERICAN: DDC) ("DDC" or the "Company"), a global Asian food platform and digital asset treasury company, released its unaudited financial results for the twelve months ended December 31, 2025. The Company's results reflect continued progress in its core consumer food business, alongside the initial build-out of its Bitcoin treasury strategy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260421754030/en/DDC Enterprise Repor

    4/21/26 8:26:00 AM ET
    $DDC
    Packaged Foods
    Consumer Staples

    DDC Announces Fiscal Year 2025 Earnings Conference Call for April 21, 2026

    DDC Enterprise Limited (NYSEAMERICAN: DDC) ("DDC" or the "Company"), a global Asian food platform and digital asset treasury company, today announced that it will report its financial results for fiscal year 2025 on Tuesday, April 21, 2026 at 8:30 AM EDT. DDC will cover the financial results for the twelve months ended December 31, 2025, as well as provide a business update. DDC will release its earnings before the call at approximately 7:30 AM EDT on April 21, 2026. A copy of the earnings release will be available on the Company's Investor Relations website at https://ir.ddc.xyz/. Conference Call Information: Date: April 21, 2026 Time: 8:30 AM EDT Participant Call Links: Liv

    4/15/26 9:00:00 AM ET
    $DDC
    Packaged Foods
    Consumer Staples